12:00 AM
Feb 27, 2012
 |  BC Week In Review  |  Company News  |  Deals

Abcodia, VolitionRx deal

The companies partnered to discover and develop nucleosome-based diagnostic tests for lung, colorectal and pancreatic cancer. VolitionRx will use...

Read the full 74 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >